BRAF and neoplasm: Further study is needed in a larger cohort to identify the potential of these identified changes, and also to fully understand the mechanisms that lead to BRAF tumours becoming chemoresistant and having a poorer prognosis, as this is unlikely to be due to a single pathway phenomenon.